Plain-English translation of NCT06188689 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are evaluating a new diagnostic test for calcium release deficiency syndrome (CRDS), a rare genetic heart condition caused by changes in the RyR2 gene. Currently, diagnosing CRDS requires time-consuming lab tests that aren't widely available. This study tests whether a special heart pacing procedure—where doctors briefly speed up your heart rhythm and then watch how it recovers—can show a distinctive pattern that signals CRDS.
Most people with CRDS likely go undiagnosed because the current diagnostic method is slow, complex, and only available at specialized research centers. Finding a simpler, faster way to diagnose CRDS using standard heart testing could help doctors identify at-risk patients earlier and prevent life-threatening complications.
You likely qualify if…
You likely don't qualify if…
You will undergo a specialized heart pacing procedure, similar to a standard electrophysiology study. Doctors will place temporary pacing wires and deliver brief, controlled electrical pulses to speed up your heart rhythm, then observe the electrical activity on your heart's surface as it recovers. The entire procedure typically takes less than an hour and is performed in a hospital setting under careful monitoring.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States
Belgium